← Back to Screener
Lifeward Ltd. Ordinary Shares (LFWD)
Price$7.52
Favorite Metrics
Price vs S&P 500 (26W)-32.28%
Price vs S&P 500 (4W)-8.75%
Market Capitalization$11.49M
All Metrics
Book Value / Share (Quarterly)$9.08
P/TBV (Annual)0.81x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)62.63%
Cash Flow / Share (Quarterly)$-12.29
Price vs S&P 500 (YTD)-6.02%
Gross Margin (TTM)35.60%
Net Profit Margin (TTM)-120.65%
EPS (TTM)$-16.62
10-Day Avg Trading Volume0.01M
EPS Excl Extra (TTM)$-16.62
Revenue Growth (5Y)39.41%
EPS (Annual)$-39.96
ROI (Annual)-153.55%
Gross Margin (Annual)32.01%
Net Profit Margin (5Y Avg)-227.30%
Cash / Share (Quarterly)$1.39
Revenue Growth QoQ (YoY)-14.66%
ROA (Last FY)-94.93%
Revenue Growth TTM (YoY)4.96%
EBITD / Share (TTM)$-9.79
ROE (5Y Avg)-60.74%
Operating Margin (TTM)-121.10%
Cash Flow / Share (Annual)$-29.59
P/B Ratio0.90x
P/B Ratio (Quarterly)0.88x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)0.47x
Net Interest Coverage (TTM)-13.39x
ROA (TTM)-108.74%
EPS Incl Extra (Annual)$-39.96
Current Ratio (Annual)2.08x
Quick Ratio (Quarterly)0.92x
3-Month Avg Trading Volume0.02M
52-Week Price Return-59.29%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$2.04
P/S Ratio (Annual)0.45x
Asset Turnover (Annual)0.84x
52-Week High$18.60
Operating Margin (5Y Avg)-223.36%
EPS Excl Extra (Annual)$-39.96
26-Week Price Return-23.54%
Quick Ratio (Annual)1.29x
13-Week Price Return-13.61%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)1.92x
Enterprise Value$11.492
Revenue / Share Growth (5Y)43.02%
Asset Turnover (TTM)0.74x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)2.82x
Pretax Margin (Annual)-112.61%
Cash / Share (Annual)$9.19
3-Month Return Std Dev89.53%
Gross Margin (5Y Avg)39.44%
Net Income / Employee (TTM)$-0
ROE (Last FY)-153.55%
Net Interest Coverage (Annual)-936.50x
EPS Basic Excl Extra (Annual)$-39.96
Receivables Turnover (TTM)4.39x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-16.62
Receivables Turnover (Annual)5.63x
ROI (TTM)-181.05%
P/S Ratio (TTM)0.47x
Pretax Margin (5Y Avg)-225.04%
Revenue / Share (Annual)$35.43
Tangible BV / Share (Annual)$25.68
Price vs S&P 500 (52W)-94.39%
Year-to-Date Return-1.88%
5-Day Price Return4.46%
EPS Normalized (Annual)$-39.96
ROA (5Y Avg)-43.20%
Net Profit Margin (Annual)-112.78%
Month-to-Date Return2.41%
EBITD / Share (Annual)$-40.02
Operating Margin (Annual)-114.36%
LT Debt / Equity (Annual)0.00x
ROI (5Y Avg)-60.74%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-16.62
P/TBV (Quarterly)0.85x
P/B Ratio (Annual)0.81x
Inventory Turnover (TTM)2.13x
Pretax Margin (TTM)-120.52%
Book Value / Share (Annual)$25.68
Price vs S&P 500 (13W)-16.48%
Beta0.28x
Revenue / Share (TTM)$26.11
ROE (TTM)-181.05%
52-Week Low$4.14
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.13
4.13
4.13
4.13
Industry Peers — Orthopedic & Prosthetic Devices(25)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
LFWDLifeward Ltd. Ordinary Shares | 0.47x | 39.41% | 35.60% | -121.10% | $7.52 |
ISRGIntuitive Surgical Inc. | 16.54x | 18.22% | 66.00% | 29.27% | $465.60 |
EWEdwards Lifesciences Corp | 7.77x | 6.70% | 78.01% | 18.41% | $81.44 |
STESTERIS plc | 3.81x | 12.49% | 44.11% | 17.03% | $226.41 |
ZBHZimmer Biomet Holdings, Inc. | 2.31x | 3.22% | 69.71% | 13.34% | $95.48 |
ALGNAlign Technology Inc | 3.41x | 10.30% | 68.27% | 13.53% | $191.66 |
SNNSmith & Nephew plc | 2.37x | 6.21% | 68.01% | 12.88% | $34.21 |
MSAMine Safety Incorporated | 3.60x | 6.82% | 46.46% | 19.83% | $173.50 |
ESTAEstablishment Labs Holdings Inc. | 9.30x | 20.04% | 69.32% | -18.48% | $66.93 |
ENOVEnovis Corporation | 0.68x | -6.05% | 58.16% | -50.09% | $26.27 |
CDRECadre Holdings, Inc. | 2.19x | 8.57% | 42.54% | 11.04% | $30.51 |
About
Lifeward Ltd develops and commercializes medical devices for rehabilitation and recovery, including wearable exoskeletons, powered suits, functional electrical stimulation bikes, and anti-gravity systems. The company serves multiple care settings—clinical, home, and community—with operations in the United States, Israel, and Germany.